Biofrontera
BFRI · NASDAQ
$0.804−$0.0017 (−0.21%)TodayMarket closed ·
Prev close $0.8057
About BFRI
- Employees
- 84
- Headquarters
- Woburn, Massachusetts
- Listed
- Oct 14, 2021
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- biofrontera-us.com
Leadership
| Name | Title | Since |
|---|---|---|
| Prof. Dr. Hermann Luebbert | — | 2015 |
| Eugene Frederick Leffler | — | — |
| George Jones | — | — |
| Heikki Lanckriet | — | — |
| John Borer | — | — |
| Beth Hoffman | — | — |
| Kevin Weber | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2021: $24.10M total revenue
By product
- Product [Member]$24.04M99.8%
- Revenues Related Party [Member]$57.00K0.2%
Similar companies
Companies in the same industry as Biofrontera
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.